The restoration of the miR-34a levels in 5-FU-resistant CRC through the treatment with regorafenib induced the decrease of WNT1 and, indirectly, of MYC and NOTCH1 expression, leading to an inhibition of the stemness [21]. Here, MYC is linked to colorectal carcinoma.